All In MedTech

Device Trial Radar · NCT05236088

The Effects of Neuromuscular Electrical Stimulation in Individuals With Urinary Incontinence After Prostatectomy

Last checked: Nov 20, 2026Latest source record: Feb 11, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

50

Planned (sponsor's estimate)

Start

Mar 2022

Primary completion

Jul 2022

Study completion Mar 2023

Sponsor

Lead sponsor
Ankara Yildirim Beyazıt UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 11, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
Male only, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this study is to investigate the effects of neuromuscular electric stimulation on urinary symptoms, quality of life, sexual function, perception of improvement and patient satisfaction in individuals with post-prostatectomy urinary incontinence

Conditions

  • Urinary Incontinence

Interventions

  • Neuromuscular electrical stimulation applicationDevice

    It was applied with INNOVO brand (Atlantic Therapeutics, Galway, Ireland) device. It was applied for 30 minutes 3 days a week during 4 weeks

  • Sham neuromuscular electrical stimulation applicationDevice

    Sham group will be applied from the same device, again 3 days a week for 30 minutes during 4 weeks, but no current will be given from the device.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Urinary incontinence severityTime frame: change from baseline at 4 weeks

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.